Abstract
Purpose
Knowledge of prevalence and dynamics of high-risk human papilloma virus (HR HPV) is essential for formulating effective prevention strategies for cervical cancer.
Methods
A cross-sectional observation study was carried out among sexually active women of rural Tamil Nadu for estimating the cervical HR-HPV prevalence and their persistence using Hybrid Capture 2 technique and Linear Array HPV genotyping method with follow-up at 12 and 36 months. Data related to prevalence, epidemiological determinants, genotype distribution and persistence of infection was analyzed statistically for significance.
Results
A total of 193 of 1523 women were tested positive for HR HPV, a prevalence rate of 12.7%. The HR HPV prevalence peaked at 25–29 years (16.4%) and consistent across 30–50 years of age (13%). Socio-demographic, sexual and reproductive characteristics had no association with HPV prevalence. HPV 16 was the predominant type followed by 52, 58, 35 and 18 in order of their prevalence. The prevalence rate of HR-HPV among the positive cases was 23.8%, with 16% type specific persistence at 12 months. Overall, 91.7% women had cleared the infection and 3.2% was detected with new HPV infection in three years. HPV types 16 and 52 were the common persistent genotypes.
Conclusion
HPV 16 is the most prevalent and persistent genotype in the Indian population. However, the current vaccine controlled genotype 18 is not among the top five persistent types. More data on diverse population within the country are required to draw conclusive evidence if a tailormade vaccine is the best option towards cervix cancer control.
Similar content being viewed by others
References
Denny L. Cervical cancer: prevention and treatment. Discovery Med. 2012;14(75):125–31.
Ferlay JEM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9. https://doi.org/10.1002/(sici)1096-9896(199909)189:1%3c12::aid-path431%3e3.0.co;2-f.
Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65. https://doi.org/10.1136/jcp.55.4.244.
Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Women’s Health. 2015;7:405–14. https://doi.org/10.2147/ijwh.s50001.
Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4-7. https://doi.org/10.1016/j.ygyno.2008.07.045.
World Health Organization. Comprehensive cervical cancer control: A guide to essential practice. 2nd ed. Geneva: World Health Organization; 2014.
Villa LL. Laboratory methods for detection of human papillomavirus infection human papillomavirus: a practical guide for urologists. Berlin: Springer; 2009. p. 23–30.
Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJF, et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer. 2003;107(1):127–33. https://doi.org/10.1002/ijc.11350.
Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahé C, Plummer M, et al. Papillomavirus infection in rural women in southern India. Br J Cancer. 2005;92(3):601–6. https://doi.org/10.1038/sj.bjc.6602348.
Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in Rural India. N Engl J Med. 2009;360(14):1385–94. https://doi.org/10.1056/NEJMoa0808516.
Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis. 2005;5(1):116. https://doi.org/10.1186/1471-2334-5-116.
Bhatla N, Dar L, Rajkumar Patro A, Kumar P, Pati SK, Kriplani A, et al. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Pathol Official J Int Soc Gynecol Pathol. 2008;27(3):426–30. https://doi.org/10.1097/PGP.0b013e31816085ba.
Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (London, England). 2005;366(9490):991–8. https://doi.org/10.1016/s0140-6736(05)67069-9.
Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004;90(3):638–45. https://doi.org/10.1038/sj.bjc.6601515.
de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453–9. https://doi.org/10.1016/s1473-3099(07)70158-5.
Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–99. https://doi.org/10.1086/657321.
Molano M, Van den Brule A, Plummer M, Weiderpass E, Posso H, Arslan A, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003;158(5):486–94. https://doi.org/10.1093/aje/kwg171.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. England J Med. 2003;348(6):518–27. https://doi.org/10.1056/NEJMoa021641.
Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169(2):235–40. https://doi.org/10.1093/infdis/169.2.235.
Srivastava S, Gupta S, Roy JK. High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. J Biosci. 2012;37(1):63–72. https://doi.org/10.1007/s12038-012-9181-y.
Manga MM, Fowotade A, Abdullahi YM, El-Nafaty AU, Adamu DB, Pindiga HU, et al. Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infectious Agents Cancer. 2015;10:39. https://doi.org/10.1186/s13027-015-0035-8.
Sauvaget C, Nene BM, Jayant K, Kelkar R, Malvi SG, Shastri SS, et al. Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women. Sex Transm Dis. 2011;38(10):902–6. https://doi.org/10.1097/OLQ.0b013e318223be5f.
Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer. 2004;91(5):942–53. https://doi.org/10.1038/sj.bjc.6602049.
Datta P, Bhatla N, Pandey RM, Dar L, Patro AR, Vasisht S, et al. Type-specific incidence and persistence of HPV infection among young women: a prospective study in North India. Asian Pacific J Cancer Prevent APJCP. 2012;13(3):1019–24. https://doi.org/10.7314/apjcp.2012.13.3.1019.
Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer Official J Int Gynecol Cancer Soc. 2008;18(1):71–9. https://doi.org/10.1111/j.1525-1438.2007.00959.x.
Pillai RM, Babu JM, Jissa VT, Lakshmi S, Chiplunkar SV, Patkar M, et al. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India. Int J Gynecol Cancer Official J Int Gynecol Cancer Soc. 2010;20(6):1046–51. https://doi.org/10.1111/IGC.0b013e3181e02fe0.
Human Papillomaviruses (1995) IARC monographs on the evaluation of carcinogenic risks to humans: IARC.
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315–24. https://doi.org/10.1093/jnci/djq001.
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New England J Med. 1998;338(7):423–8. https://doi.org/10.1056/nejm199802123380703.
Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415–23. https://doi.org/10.1086/315086.
Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017. https://doi.org/10.3390/v9100267.
Acknowledgements
The authors thank DCS project screening team, Chennai and the community leaders of Chengelpet and Tambaram taluk who helped us conduct the study. The editing and formatting of manuscript by Dr.Vani Suresh, Research Scholar Cancer Institute (WIA), is thankfully acknowledged.
Funding
This study was supported by pooled resources from Corporate Social Responsibility (CSR) funds, donated to the Cancer Institute (WIA).
Author information
Authors and Affiliations
Contributions
MJS Physician—Gynec Oncology/Preventive Oncology—Primary Investigator was responsible for the overall management of the study that includes recruitment of subjects, train the staff to collect cervical samples, interpretation of test results, clinical management and follow-up care of the study subjects. She also contributed to manuscript writing and submission. SR Epidemiologist/ Biostatistician—Co-investigator was responsible for the design of the study, randomization of units and data analysis. VB Senior Microbiologist—Co-investigator was responsible for analysis of the samples for the presence of high-risk HPV DNA and issue of the results.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Consent to participate
All participants provided written informed consent prior to enrolment in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Subramanian, M.J., Rajaraman, S. & Vijayakumar, V. A Community-Based Study on Prevalence, Genotype Distribution and Persistence of High-Risk Human Papilloma Virus Infection of Uterine Cervix in Rural South India. Indian J Gynecol Oncolog 19, 16 (2021). https://doi.org/10.1007/s40944-021-00496-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40944-021-00496-x